Produkty 1856-26-4

CAS 1856-26-4 występuje w naszej ofercie pod nazwami: Hydrocortisone Impurity 27, 21-Acetyl-17,21-dihydroxy-pregna-4,8-diene-3,11,20-trione, >95% (HPLC). Oferty producentów: Chemat Brand, TRC. Dostępne opakowania: on request, 25mg, 50mg, 5mg.

Hydrocortisone Impurity 27
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
21-Acetyl-17,21-dihydroxy-pregna-4,8-diene-3,11,20-trione, >95% (HPLC)
TRC
  • opakowanie: 25mg, 50mg, 5mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[2-[(10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate (CAS 1856-26-4) to związek chemiczny o wzorze sumarycznym C23H28O6 i masie molowej 400.5 g/mol. Nazwa systematyczna IUPAC: [2-[(10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate. InChIKey: BHCIJKNFADQBEV-ZMVGRULKSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H28O6
Masa molowa400.5 g/mol
Nazwa IUPAC[2-[(10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChIKeyBHCIJKNFADQBEV-ZMVGRULKSA-N
SMILESCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)C3=C2CCC4=CC(=O)CC[C@@]43C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 21-Acetyl-17,21-dihydroxy-pregna-4,8-diene-3,11,20-trione
Izomery (ten sam wzór sumaryczny)
3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene C23H28O6
(2R)-2-[(3aR,5R,6S,6aR)-2,2-dimethyl-6-phenylmethoxy-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]-2-phenylmethoxyethanol C23H28O6
[2-[(8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O6
[2-[(8S,9S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O6
[2-[(1S,2S,10S,11S,14R,15S,17S)-14-hydroxy-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-14-yl]-2-oxoethyl] acetate C23H28O6
[(8S,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate C23H28O6
(1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylic acid C23H28O6
tert-butyl 2-[3-[3-(3,4-dimethoxyphenyl)propanoyl]phenoxy]acetate C23H28O6
[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O6
(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-4,5-bis(phenylmethoxy)-6-prop-2-enoxyoxan-3-ol C23H28O6
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H28O6
(9R,10S)-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene C23H28O6